Roth/MKM Starts Globus Medical (GMED) at Buy, 'concerns over sales force attrition are exaggerated'
Tweet Send to a Friend
(Updated - October 19, 2023 4:10 PM EDT)
Roth/MKM analyst Jason Wittes initiates coverage on Globus Medical (NYSE: GMED) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Jason Wittes initiates coverage on Globus Medical (NYSE: GMED) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
